Metabolic bone diseases, both osteoporosis and osteomalacia, complicate hepato-biliary disorders (Atkinson, Nordin, and Sherlock, 1956; Lichtwitz, Cachin, Hioco, Tutin, and de Seze, 1959) . Osteoporosis is characterized by a diminished volume of bone and is the end result of many processes.
Osteomalacia is a disease produced by a lack of cholecalciferol (vitamin D3) Received for publication 3 July 1974. findings the present study was undertaken to investigate the effect of intravenous calcium infusions in 14 patients with primary biliary cirrhosis who complained of bone pain, all of whom had received parenteral vitamin D. Plasma calcium and phosphate concentrations, plasma alkaline phosphate activity, and intestinal calcium absorption were measured and bone biopsies performed.
Methods

CALCIUM INFUSION
Each patient received a calcium infusion daily for 12 consecutive days. Each infusion consisted of calcium gluconate diluted in 5 % dextrose to about 500 ml and administered intravenously over four hours. The dose of calcium was 1.5 mg/kg body weight (low dose) or 15 mg/kg body weight (high dose).
In seven patients a pulse of 10 ,uCi 47Ca was added to the first infusate. The activity remaining in the drip bottle and tubing was checked. The fate of the pulse was followed by stool and urine collections, and in six patients by whole body counting.
The relief of bone pain in primary biliary cirrhosis with calcium infusions 47Ca in 200 ml of milk (calcium content approximately 240 mg) was given orally to the patients after overnight fasting. Patients remained fasting for a further three hours after taking the isotope. Urine was collected for two days to check renal excretion of 47Ca in order to exclude any patient in whom excessive renal excretion would invalidate this method of measuring calcium absorption. The whole body counter result was expressed as the percentage retention of the isotope at seven days.
BONE BIOPSY
Decalcified and undecalcified sections and microradiographs were prepared from all sections (Drury and Wallington, 1967) .
A qualitative examination was made of the architecture (gross anatomy), structure (collagen organization), periosteocytic mineral distribution, and osteoid mineralization (calcification front).
A quantitative assessment was made of bone area as a percentage of cancellous compartment, osteoid area as a percentage of cancellous compartment, osteoid as a percentage of bone surface, and resorption as a percentage of bone surface.
The interpretation of bone biopsies has been described in detail by Byers (1974 The 14 patients were all suffering from primary biliary cirrhosis diagnosed according to recognized criteria (Sherlock and Scheuer, 1973; Sherlock, 1974 (Galante, Colston, Evans, Byfield, Matthews, and MacIntyre, 1973) . It was expected that calcium infusions would, through the feed-back control mechanism, tend to reduce the rate of renal synthesis of 1,25-dihydroxycholecalciferol with a consequent decrease rather than increase in intestinal calcium absorption.
Two of the patients had histological evidence of osteomalacia, despite long-term intramuscular vitamin D therapy. In one of these two patients a bone biopsy after treatment showed healing of the osteomalacia. In the 14 patients studied this constitutes the only objective evidence of a beneficial effect of the infusions. Healing of osteomalacia was also seen in a further patient with secondary biliary cirrhosis whose pain was relieved by infusion treatment.
The retention of radiocalcium-labelled infusate, and presumably infused calcium, showed wide variations between patients. One patient with osteomalacia appeared to have an exceptional avidity-for infused calcium-retaining 72% of the infused radioisotope after 12 days. A similar result was found in the patient with secondary biliary cirrhosis and osteomalacia. These high retentions, with corresponding low urinary outputs, resemble the results found in osteomalacia by the calcium infusion test (Nordin and Fraser, 1956;  Kehayoglou, Holdsworth, Agnew, Whelton, and Sherlock, 1968) . The highest urinary outputs of infused radiocalcium were found in two patients with normal calcium absorption. In two of the other patients there was histological evidence of osteoporosis and in the remainder iliac crest biopsy was normal. In view of the bone pain it is possible that there could have been metabolic bone disease at other sites.
The subjective relief of bone pain was similar to that reported by Pak et al (1969) in six patients with idiopathic osteoporosis. Sekel (1973) also reported the relief of bone pain following a course of calcium infusions in patients with Paget's disease of bone and noted 'striking relief from pain after the third day of infusion and relief has persisted sixteen weeks after the infusion ceased'. In contrast to the findings of Pak et al (1969) , after the course of calcium infusions we found no changes in calcium retention or in bone biopsies, with one exception (case 10). Their studies, however, were performed on patients with idiopathic osteoporosis.
The mechanism of the effectiveness of intravenous calcium infusion therapy in the relief of bone pain in the group ofpatients with primary biliary cirrhosis studied here is not clear. Pak et al (1969) suggested that hypercalcaemia induced by an intravenous infusion of calcium might suppress endogenous parathyroid hormone secretion and stimulate calcitonin secretion which would therefore lead to the induction of a positive calcium balance and the extent of this effect would depend on the dose of calcium. This view is consistent with the more rapid onset of relief from bone pain in those patients who received the high dose infusion. It is, however, difficult to understand why the infusion of only a relatively small amount of calcium, as given in the low dose therapy, should produce a dramatic clinical response. In view of the entirely subjective nature of the response obtained it could be argued that the effect was a placebo reaction. Despite these arguments it is concluded that this form of therapy is of value in the relief of the bone pain which occurs in patients with primary biliary cirrhosis despite vitamin D therapy, and possibly of that associated with hepatic osteodystrophy in other hepatobiliary disorders. 
